APA引文

Tourdot, B. E., Stoveken, H., Trumbo, D., Yeung, J., Kanthi, Y., Edelstein, L. C., . . . Holinstat, M. (2018). Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics. Arterioscler Thromb Vasc Biol.

Citação norma Chicago

Tourdot, Benjamin E., Hannah Stoveken, Derek Trumbo, Jennifer Yeung, Yogendra Kanthi, Leonard C. Edelstein, Paul F. Bray, Gregory G. Tall, and Michael Holinstat. "Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics." Arterioscler Thromb Vasc Biol 2018.

MLA引文

Tourdot, Benjamin E., et al. "Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics." Arterioscler Thromb Vasc Biol 2018.